Keynote address: Bioreductive mechanisms
- 31 December 1992
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (4), 631-637
- https://doi.org/10.1016/0360-3016(92)90493-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Synthesis and evaluation of .alpha.-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of .alpha.-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxinsJournal of Medicinal Chemistry, 1990
- Mechanisms of cell deathTrends in Pharmacological Sciences, 1989
- Role of Ca2+ in toxic cell killingTrends in Pharmacological Sciences, 1989
- Molecular mechanisms for the hypoxiadependent activation of 3-amino-1,2,4-benzotriazine-1, 4-dioxide (SR 4233)Biochemical Pharmacology, 1988
- Isolation and Structure of a Covalent Cross-Link Adduct Between Mitomycin C and DNAScience, 1987
- Nitroimidazole bioreductive metabolismBiochemical Pharmacology, 1987
- Metabolism and reactions of quinoid anticancer agentsPharmacology & Therapeutics, 1987
- A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069The British Journal of Radiology, 1986
- Interaction of the aziridine moiety of RSU-1069 with nucleotides and inorganic phosphateBiochemical Pharmacology, 1986
- One-electron-transfer reactions in biochemical systems V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase)Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1970